1. Children born to women with polycystic ovary syndrome—short- and long-term impacts on health and development
- Author
-
Eszter Vanky, David H. Abbott, and Liv Guro Engen Hanem
- Subjects
Male ,0301 basic medicine ,Offspring ,Health Status ,Maternal Health ,Ethnic group ,Risk Assessment ,03 medical and health sciences ,Child Development ,0302 clinical medicine ,Child of Impaired Parents ,Pregnancy ,Risk Factors ,medicine ,Humans ,Child ,Reproductive health ,030219 obstetrics & reproductive medicine ,business.industry ,Age Factors ,Child Health ,Infant, Newborn ,Infant ,Obstetrics and Gynecology ,Prognosis ,medicine.disease ,Polycystic ovary ,Comorbidity ,Obesity ,Fertility ,030104 developmental biology ,Reproductive Medicine ,Child, Preschool ,Prenatal Exposure Delayed Effects ,Female ,Disease Susceptibility ,business ,Infertility, Female ,Polycystic Ovary Syndrome ,Demography - Abstract
Maternal PCOS status may negatively influence offspring infant and childhood growth, cardiometabolic health, reproductive health, and neurodevelopment. Current findings across studies are divergent, often because of small numbers of subjects, as well as heterogeneous selection criteria, ethnicities, and definitions of control groups. Coexisting maternal obesity, pregnancy complications, and comorbidity make it difficult to identify the contribution of maternal PCOS. Large, prospective, international, multiethnic studies with standardized investigation protocols and questionnaires on PCOS offspring health and development are needed.
- Published
- 2019